BGLC

BioNexus Gene Lab Corp. specializes in blood-based genomic screening, focusing on the early detection of predisposed diseases through the analysis of ribonucleic acid (RNA). The company offers a less-invasive blood test that assesses an individual's risk for eight common cancers, two inflammatory diseases, and osteoarthritis. BioNexus employs FDA-approved reagents and instruments to ensure the quality of its testing services, targeting healthcare providers and individuals seeking proactive health management.